<table id="_Refid_491a4c34-5921-45c2-89c7-320dd7d0a" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3. Effect of Coadministered Drugs on the Pharmacokinetics of Atorvastatin</caption>
<col width="25%"></col>
<col width="25%"></col>
<col width="25%"></col>
<col width="25%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Coadministered Drug and Dosing Regimen</content>
</paragraph>
</td>
<td align="center" colspan="3" stylecode="Rrule Botrule Toprule ">
<paragraph>
<content stylecode="bold">Atorvastatin</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> </paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>
<content stylecode="bold">Dose (mg)</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>
<content stylecode="bold">Change in AUC</content>
<footnote id="_Refid-6acbc4a4-4343-47d6-85d5-1b3d4dace">Data given as x-fold change represent a simple ratio between coadministration and atorvastatin alone (i.e., 1-fold = no change). Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change).</footnote>
</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>
<content stylecode="bold">Change in Cmax</content>
<footnoteref idref="_Refid-6acbc4a4-4343-47d6-85d5-1b3d4dace"></footnoteref>
<content stylecode="bold">
<sup> </sup>
</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnote id="_Refid-9423c421-4404-4560-af1f-8ba1ada19">See Sections 5.1 and 7 for clinical significance.</footnote>Cyclosporine 5.2 mg/kg/day, stable dose</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 28 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 8.7 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑10.7 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 9.4 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 8.6 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Telaprevir 750 mg q8h, 10 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>20 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 7.88 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 10.6 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>,<footnote id="_Refid-863865c6-4511-458c-8d34-433ab77ef">The dose of saquinavir plus ritonavir in this study is not the clinically used dose. The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study. Therefore, caution should be applied and the lowest dose necessary should be used.</footnote>Saquinavir 400 mg BID/ritonavir 400 mg BID, 15 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 3.9 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 4.3 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Clarithromycin <br/>500 mg BID, 9 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>80 mg QD for 8 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 4.4 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 5.4 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 3.4 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2.25 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Itraconazole 200 mg QD, 4 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 3.3 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 20%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2.53 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2.84 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Fosamprenavir 1400 mg BID, 14 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2.3 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 4.04 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Nelfinavir 1250 mg BID, 14 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 28 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 74%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2.2 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Grapefruit Juice, 240 mL QD <footnote id="_Refid-b39b38f1-8c8d-4be3-80bc-923e6ac51">Greater increases in AUC (up to 2.5-fold) and/or C<sub>max</sub> (up to 71%) have been reported with excessive grapefruit consumption (≥ 750 mL to 1.2 liters per day).</footnote>
</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 37%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 16%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Diltiazem 240 mg QD, 28 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 51%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>No change</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Erythromycin 500 mg QID, 7 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 33%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 38%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Amlodipine 10 mg, single dose</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>80 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 15%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 12%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Cimetidine 300 mg QD, 4 weeks</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 2 weeks</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ Less than 1%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 11%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Colestipol 10 mg BID, 28 weeks</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg QD for 28 weeks</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Not determined</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 26%<footnote id="_Refid-2a45f45a-f4a3-438b-88e4-7fc89e5cd">Single sample taken 8 to 16 h post-dose.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Maalox TC<sup>®</sup> 30 mL QD, 17 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg QD for 15 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 33%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 34%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Efavirenz 600 mg QD, 14 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>10 mg for 3 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 41%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 1%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Rifampin 600 mg QD, 7 days (coadministered) <footnote id="_Refid-0c89e00e-5530-4841-aa4c-2b0091c56">Due to the dual interaction mechanism of rifampin, simultaneous coadministration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations.</footnote>
</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 30%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2.7 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Rifampin 600 mg QD, 5 days (doses separated) <footnoteref idref="_Refid-0c89e00e-5530-4841-aa4c-2b0091c56"></footnoteref>
</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 80%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ 40 %</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Gemfibrozil 600 mg BID, 7 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 35%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ Less than 1%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>
<footnoteref idref="_Refid-9423c421-4404-4560-af1f-8ba1ada19"></footnoteref>Fenofibrate 160 mg QD, 7 days</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 3%</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↑ 2%</paragraph>
</td>
</tr>
</tbody>
</table>